Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy of MEK inhibition in patients with histiocytic neoplasms. | Nature | 2019 | 30867592 | PubTator, text mining | PubMed |
| Identification of exosomal and non‑exosomal microRNAs associated with the drug resistance of ovarian cancer. | Mol Med Rep | 2019 | 30864705 | PubTator, text mining | PubMed |
| Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas. | Nat Med | 2019 | 30833747 | PubTator, text mining | PubMed |
| Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers. | J Thorac Oncol | 2019 | 30831205 | PubTator, text mining | PubMed |
| Structural characterization of three polysaccharides from the roots of Codonopsis pilosula and their immunomodulatory effects on RAW264.7 macrophages. | Int J Biol Macromol | 2019 | 30831168 | PubTator, text mining | PubMed |
| A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS-Mutant Melanoma. | Cancer Res | 2019 | 30819666 | PubTator, text mining | PubMed |
| Regulation of c-Raf Stability through the CTLH Complex. | Int J Mol Sci | 2019 | 30795516 | PubTator, text mining | PubMed |
| Comparison and structural characterization of polysaccharides from natural and artificial Se-enriched green tea. | Int J Biol Macromol | 2019 | 30794901 | PubTator, text mining | PubMed |
| Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence. | Front Oncol | 2019 | 30788289 | PubTator, text mining | PubMed |
| Functional analysis finds differences on the muscle transcriptome of pigs fed an n-3 PUFA-enriched diet with or without antioxidant supplementations. | PLoS One | 2019 | 30785965 | PubTator, text mining | PubMed |
| Targeting Alterations in the RAF-MEK Pathway. | Cancer Discov | 2019 | 30770389 | PubTator, text mining | PubMed |
| The ERK Pathway: Molecular Mechanisms and Treatment of Depression. | Mol Neurobiol | 2019 | 30737641 | PubTator, text mining | PubMed |
| Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically. | Leukemia | 2019 | 30737482 | PubTator, text mining | PubMed |
| Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines. | J Exp Clin Cancer Res | 2019 | 30691487 | PubTator, text mining | PubMed |
| Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice. | EBioMedicine | 2019 | 30686755 | PubTator, text mining | PubMed |
| Development of Highly Sensitive Biosensors of RAF Dimerization in Cells. | Sci Rep | 2019 | 30679688 | PubTator, text mining | PubMed |
| Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report. | Drug Des Devel Ther | 2019 | 30666091 | PubTator, text mining | PubMed |
| Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC. | J Thorac Oncol | 2019 | 30664990 | PubTator, text mining | PubMed |
| B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. | Oncogene | 2019 | 30659267 | PubTator, text mining | PubMed |
| Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing. | BMC Med Inform Decis Mak | 2019 | 30658646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=59